Shares of Syneos Well being, Inc. (NASDAQ: SYNH – get rating) has been given a median ranking of ‘pending’ by the 13 ranking businesses that cowl the corporate. Market beat evaluation report. Eight Analysis her analysts rated shares with maintain suggestions, and two issued purchase suggestions for the corporate. The typical 12-month goal worth for brokerages that coated equities final 12 months was $51.11.
A lot of analysts have commented on the SYNH inventory. Barclays lowered its worth goal on Syneos Well being shares from $60.00 to his $30.00 in a report on Sunday, November 6, setting the corporate’s ranking to “obese.” Robert W. Baird lowered his share worth goal for Syneos Well being from his $80.00 to his $42.00 in a analysis report on Monday, Nov. 7, setting the corporate’s valuation to “Outperform.” StockNews.com featured Syneos Well being shares in a analysis report on Wednesday, October twelfth. They set a “pending” ranking on the corporate. JPMorgan Chase & Firm downgraded Syneos Well being shares from ‘obese’ ranking to ‘impartial’ and worth goal to $53.00 from $85.00 in a analysis report on Tuesday, Oct. 18. I pulled it down. Lastly, Guggenheim downgraded Syneos Well being shares from a purchase ranking to a impartial ranking in his Wednesday Sept. 14 analysis report.
Institutional Traders Give attention to Syneos Well being
Hedge funds and different institutional buyers just lately modified their stakes within the firm. Eagle Asset Administration Inc. acquired a brand new stake in his Syneos Well being price $46,487,000 within the second quarter. Cooke & Bieler LP elevated his Syneos Well being place by 20.2% within the second quarter. Cooke & Bieler LP now owns 2,836,728 shares of the corporate price $23337,000 after he bought an extra 477,225 shares in the course of the earlier quarter. Macquarie Group Ltd. expanded his place in Syneos Well being by 69.9% within the third quarter. Macquarie Group Ltd. now owns 1,151,572 shares price $54,351,000 after buying an extra 473,794 shares in the course of the earlier quarter. Assenagon Asset Administration SA expanded his place at Syneos Well being by 522.6% within the third quarter. Assenagon Asset Administration SA now owns 497,456 shares price $23,455,000 after buying an extra 417,559 shares within the earlier quarter. Lastly, AQR Capital Administration LLC expanded its place in Syneos Well being by 86.8% within the second quarter. AQR Capital Administration LLC now owns 803,538 shares price $57,598,000 after buying an extra 373,351 shares in the course of the earlier quarter. At present 93.51% of the shares are owned by institutional buyers and hedge funds.
Syneos Well being shares drop 1.4%
Synchronization Opened Friday at $34.93. Syneos Well being has a 12-month low of $22.89 and a 12-month excessive of $95.68. The corporate has a fast ratio of 1.14, a present ratio of 1.14 and a debt to fairness ratio of 0.84. The corporate has a 50-day transferring common worth of $35.41 and a 200-day transferring common worth of $52.53. The corporate has a market capitalization of $3.59 billion, a PE ratio of 12.70 and a beta of 1.63.
About Syneos Well being
Syneos Well being, Inc offers biopharmaceutical outsourcing options in North America, Europe, Center East, Africa, Asia Pacific and Latin America. He operates in two segments, Scientific Options and Business Options. The Scientific Options phase offers providers for the event of diagnostics, medicine, biologics, gadgets, and digital therapeutics in phases I by way of IV of medical improvement.
Featured article
This prompt information alert was generated by Narrative Science Expertise and MarketBeat monetary information to offer our readers with the quickest and most correct reporting. This text was reviewed by MarketBeat’s editorial group previous to publication. Ship any questions or feedback about this story to contact@marketbeat.com.
Hearken to this earlier than you even contemplate Syneos Well being.
MarketBeat tracks Wall Road’s most acclaimed and high performing analysis analysts and the shares they advocate to shoppers day by day. MarketBeat five shares Prime analysts quietly whisper to shoppers to purchase now earlier than the broader market takes middle stage…and Syneos Well being wasn’t on the checklist.
Syneos Well being at the moment has a ‘maintain’ ranking amongst analysts, however the high rated analysts imagine these 5 shares are higher buys.
